The European Commission (EC) has granted CE mark approval for OptiMedica’s Catalys precision laser system for creating single-plane and multiplane arc cuts / incisions in the cornea during cataract surgery.
Catalys is a laser cataract surgery system which provides unparalleled precision and accuracy to the laser cataract procedure.
The cataract surgery system features a liquid optics interface which ensures stable system-patient attachment and optimises the optical path to the patient’s eye, along with a proprietary integral guidance system which ensures the femtosecond laser pulses are delivered safely and precisely to the intended location.
The system integrates a femtosecond laser, integrated 3D optical coherence tomography (OCT) imaging and OptiMedica’s pattern scanning technology, to deliver a precise, customised procedure for patients.
The system’s corneal incisions application is delivered via a software upgrade from OptiMedica and is anticipated to be available in markets worldwide, pending additional regulatory clearances. In addition, Catalys incorporates a graphical user interface designed to simplify the planning process and minimise procedure times.
The new CE marked indication helps cataract surgeons carry out arcuate incisions of precise orientation, length and depth, multiplane cataract incisions which are designed to be self-sealing and single plane sideport incisions.
University Eye Clinic Bochum, Germany, chairman and head Burkhard Dick said Catalys is a valuable addition to his practice, and he looks forward to continuing to work with OptiMedica to set the new standard in laser cataract surgery.
Catalys is approved by the US Food and Drug Administration and EC for performing capsulotomy and / or lens fragmentation, and is also CE mark approved for performing corneal incisions during cataract procedures.